{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"1cfda4d0-0e91-4ac4-9727-96bc7ecea577\" and issue_code = \"HCR\" sorted by filing_year descending", "rows": [[655309, "1cfda4d0-0e91-4ac4-9727-96bc7ecea577", "Q2", "BIOTECHNOLOGY INNOVATION ORGANIZATION", 6245, "BIOTECHNOLOGY INNOVATION ORGANIZATION", 2008, "second_quarter", "HCR", "Drug Safety\n    Implementation of Food & Drug Administration Amendments Act of 2007  \n            Clinical Trial Registry and Results Databases   \n            Risk Management Plans Drug Safety Cont...   \n     Heparin Contamination     \n     Counterfeit Drugs\n     FDA Globalization Act of 2008\n     H.R. 5839 Safeguarding America's Pharmaceuticals Act of 2008\n     H.R. 3610: The Food and Drug Import Safety Act of 2007\n    \nStem Cell Research      \n\nMedicaid Rebates\n     H.R. 1424\n     H.R. 6331\n     H.R. 3162\n     H.R. 1367\n     S.3101\n     Medicaid/Medicare Packages\n     Dual Proportionality \n     Medicaid Rebates in Hospital Outpatient Setting\n          CMS AMP Regulations\n           \nHuman Growth Hormone Regulation\n     S.877\n     H.R. 4911\n\nFollow-on Biologics\n     H.R. 1038\n     H.R. 1956\n     H.R. 5629\n     S. 1695    \n\nFDA Regulatory Processes for First-Time Filers\n\nFunding for Biomedical Advanced Research & Development Authority (BARDA)  \n      Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009\n      FY 2008 Supplemental Appropriations Bill (H.R. 2642)\n\nVaccine Financing\n      National Vaccine Advisory Committee Draft Recommendations\n\nVaccines for Children Program\n       National Vaccine Advisory Committee Draft Recommendations\n\nInfluenza Vaccine Supply and Immunization Recommendations\n\nBarriers and Incentives Related to Personalized Medicine\n\nOutpatient Prospective Patient Services \n      S. 3101: Medicare Improvements for Patients and Providers Act of 2008\n\nIn Vitro Diagnostics\n     Regulatory Oversight Comparative Effectiveness Program Initiatives\n          H.R. 6331\n          S. 3101\n          Medicare/Medicaid Packages      \n\nInternational Market Access for U.S. Healthcare Products\n         Healthcare Sector Advocacy/Free Trade Agreements \n         Alliance for Healthcare Competitiveness  \n\nFunding for National Institutes of Health\n         Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009\n         FY 2008 Supplemental Appropriations Bill (H.R. 2642) \n\nFunding for Bioterrorism and Emergency Preparedness\n        Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009\n         FY 2008 Supplemental Appropriations Bill (H.R. 2642) \n\nFunding for Pandemic Influenza Preparedness\n        Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009\n        FY 2008 Supplemental Appropriations Bill (H.R. 2642) \n\nFunding for the Food and Drug Administration\n        Agriculture, Rural Development, Food and Drug Administration, and Related  Agencies Appropriations Act for FY 2009\n        (Human Drug, Biologics, Food Safety, Critical Path, Regan-Udall Foundation, Center for Veterinary Medicine) \n        FY 2008 Supplemental Appropriations Bill (H.R. 2642) \n\nAccess to Investigation Drugs for Seriously Ill Patents\n         The Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (S.1956)\n\nPhysician Payments Sunshine Act\n         S.2029\n\nAccess to Drug Pricing Data  \n          H.R. 5683\n\nDrug Importation\n     Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 \n     Department of Homeland Security Appropriations Act for FY 2009 \n     Departments of Agriculture, Rural Development, Food and Drug Administration, and Related  Agencies Appropriations Act \n           for FY 2009\n     \nFDA Debarment\n     H.R. 6378: The Strengthening of FDA Integrity Act\n\nIntellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World\n      U.S. Government Positions in WTO, WHO Negotiations", "Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Council of Economic Advisers (CEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),White House Office", null, 1920000, 0, 0, "2008-07-21T18:55:10-04:00"]], "truncated": false, "filtered_table_rows_count": 1, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 and \"issue_code\" = :p1 order by filing_year desc limit 101", "params": {"p0": "1cfda4d0-0e91-4ac4-9727-96bc7ecea577", "p1": "HCR"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR", "results": [{"value": "HCR", "label": "HCR", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR", "results": [{"value": 2008, "label": 2008, "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR&filing_year=2008", "selected": false}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR", "results": [{"value": "second_quarter", "label": "second_quarter", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR&filing_period=second_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=1cfda4d0-0e91-4ac4-9727-96bc7ecea577&issue_code=HCR&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 338.97216198965907, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}